Manabu Morimoto
Yokohama City University Medical Center(JP)Kanagawa Prefectural Hospital Organization(JP)Kanagawa Cancer CenterYokohama City University(JP)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Mechanisms and Therapy
Most-Cited Works
- → Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial(2019)1,630 cited
- → Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study(2020)559 cited
- → Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma(2010)328 cited
- → Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma(2024)268 cited
- → Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial(2016)165 cited
- → Treatment of hepatocellular carcinoma with radiofrequency ablation: Radiologic-histologic correlation during follow-up periods